PROGEN Biotechnik GmbH PROGEN Biotechnik GmbH
Deutsch
  • Contact
  • Login
  • Company
    • Overview
    • People
    • Partners
    • Location
    • Quality
  • Research Products
    • Overview
    • Antibodies
    • Gene Expression and Cloning
    • Density Gradient Media
    • Purified Proteins/ Standards
    • Research Kits and Tools
  • Diagnostics
    • Overview
    • Coagulation
    • Infectious Disease
    • Inflammation and Sepsis
    • Lipid Metabolism and Diabetes
    • POCT PATHFAST® System
    • Parathormon-Tests
    • Clinical Research Kits
  • Multiplex Technology
    • Overview
    • Borrelia Tests
    • Hardware
    • Software
    • Service and Support
    • Luminex Technology
    • Molecular Diagnostics
    • Pre-Coated Beads
    • Life Science Assays
  • Home /
  • Diagnostics /
  • Inflammation and Sepsis /
  • Clinical Research

Clinical Research

1 Item(s)

per page
  1. Complement C3a-desArg ELISA

    ELISA for quantitative determination of activated complement factor C3a-desArg in plasma of patients with polytrauma, septicemia, or shock syndrome. For research in inflammatory diseases and for biocompatibility studies.
    Synonym C3a
    Cat. No. PR59011
    Quantity 96 tests
    Details

1 Item(s)

per page
Inflammation and Sepsis
  • Clinical Research
News
  • 2011-02-11
    PATHFAST® POCT System for Cardiovascular Diagnostics

  • 2011-01-14
    Expanding Competence in Luminex® Technology

  • 2010-10-28
    Exclusive distribution agreement with Asuragen

Events
  • Planet xMAP Europe
    The Grimaldi Forum, Monaco
    October 10-11, 2012

Topics
  • Biomarker Assays
  • Hantavirus
  • Borrelia Screening Tests
  • Plakophilin 2 antibodies
  • New Markers for Cell-Cell Contact
  • Lipid Research Special
Links
  • Our Multiplex Home
    www.multimetrix.com

  • DGZ – German Society for Cell Biology
    www.zellbiologie.de

  • PROGEN is member of the VDGH
    www.vdgh.de/

  • Imprint
  • Terms & Conditions
  • Order Information
  • Site Map
  • Search Terms